This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Solazyme And Sasol Olefins & Surfactants Finalize Commercial Terms For A Multi-Year Supply Of High Erucic Algal Oil

Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and Sasol Olefins & Surfactants GmbH (Sasol O&S), announced today that they have finalized commercial terms for the supply of an algal oil rich in erucic acid (C22:1) that is under development at Solazyme for production of downstream derivatives such as behenyl alcohol. Sasol O&S produces and sells C22 derivatives such as behenyl alcohol to serve a number of applications in markets that include the paper, water treatment, personal care, lubricants, oil and gas, and paints, inks, coatings and adhesives industries. In addition to the agreement on commercial supply terms, the companies also executed a letter of intent to investigate expanding to a broad collaboration, including joint manufacturing and marketing of multiple tailored oils.

“This agreement with Solazyme is testament to their tailored oil technology platform, and the fit for high performance, sustainable oils in our value chain,” said Fleetwood Grobler, Managing Director, Sasol Olefins & Surfactants. “We see a good potential to link Solazyme’s tailored oil platform with our synthetic and natural alcohols portfolio which will allow us to meet the growing demand that we see in a number of our key markets.”

The supply agreement covers multiple years with binding minimums and increasing supply quantities of tailored algal oil, with pricing to be competitive and indexed to Solazyme’s raw material costs. The companies anticipate initial commercial production of the high erucic oils currently under development at one or more Solazyme or Solazyme partner manufacturing facilities, including the Solazyme Bunge Renewable Oils facility in Orindiúva, São Paolo State, Brazil, as well as Solazyme’s manufacturing capacity in Clinton, Iowa, United States.

“Sasol O&S is a leader in the global surfactants industry, producing a diverse range of products, with excellence in both manufacturing and marketing. Combining Solazyme’s oil tailoring capability with Sasol’s industry leading capabilities can create a potential high-value business relationship across the surfactants value chain,” said Jean-Marc Rotsaert, COO, Solazyme.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs